Celldex Therapeutics
CLDX
#5029
Rank
$1.32 B
Marketcap
$19.89
Share price
-2.26%
Change (1 day)
-51.44%
Change (1 year)

P/S ratio for Celldex Therapeutics (CLDX)

P/S ratio as of March 2025 (TTM): 188

According to Celldex Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.77. At the end of 2024 the company had a P/S ratio of 240.

P/S ratio history for Celldex Therapeutics from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
2024240-23.85%
2023315-64.62%
2022891129.46%
2021388314.91%
202093.5783.15%
201910.6184.57%
20183.72-87.72%
201730.3-42.63%
201652.8-81.29%
2015282-38.08%
2014456-13.25%
20135261263.33%
201238.6211.18%
201112.4338.95%
20102.82-71.05%
20099.75-41.89%
200816.823.99%
200713.5-33.39%
200620.3-55.02%
200545.1107.81%
200421.7-43.23%
200338.3274.72%
200210.2-85.9%
200172.4

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
18.8-90.03%๐Ÿ‡บ๐Ÿ‡ธ USA
0.2729-99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
0.3050-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA
5.12-97.28%๐Ÿ‡บ๐Ÿ‡ธ USA
2.35-98.75%๐Ÿ‡บ๐Ÿ‡ธ USA
2.05-98.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA